Cargando…

Reliability of medical records in diagnosing inflammatory breast cancer in Egypt

BACKGROUND: Inflammatory breast cancer (IBC) is a rare, aggressive breast cancer diagnosed clinically by the presence of diffuse erythema, peau d’orange, and edema that arise quickly in the affected breast. This study evaluated the validity of medical records in Gharbiah, Egypt in identifying clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Le, Lynne, Schairer, Catherine, Hablas, Ahmed, Meza, Jane, Watanabe-Galloway, Shinobu, Ramadan, Mohamed, Merajver, Sofia D., Seifeldin, Ibrahim A., Soliman, Amr S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356360/
https://www.ncbi.nlm.nih.gov/pubmed/28302157
http://dx.doi.org/10.1186/s13104-017-2433-z
_version_ 1782515818214457344
author Le, Lynne
Schairer, Catherine
Hablas, Ahmed
Meza, Jane
Watanabe-Galloway, Shinobu
Ramadan, Mohamed
Merajver, Sofia D.
Seifeldin, Ibrahim A.
Soliman, Amr S.
author_facet Le, Lynne
Schairer, Catherine
Hablas, Ahmed
Meza, Jane
Watanabe-Galloway, Shinobu
Ramadan, Mohamed
Merajver, Sofia D.
Seifeldin, Ibrahim A.
Soliman, Amr S.
author_sort Le, Lynne
collection PubMed
description BACKGROUND: Inflammatory breast cancer (IBC) is a rare, aggressive breast cancer diagnosed clinically by the presence of diffuse erythema, peau d’orange, and edema that arise quickly in the affected breast. This study evaluated the validity of medical records in Gharbiah, Egypt in identifying clinical signs/symptoms of IBC. For 34 IBC cases enrolled in a case–control study at the Gharbiah Cancer Society and Tanta Cancer Center, Egypt (2009–2010), we compared signs/symptoms of IBC noted in medical records to those recorded on a standardized form at the time of IBC diagnosis by clinicians participating in the case–control study. We calculated the sensitivity and specificity of medical records as compared to the case–control study for recording these signs/symptoms. We also performed McNemar’s tests. RESULTS: In the case–control study, 32 (94.1%) IBC cases presented with peau d’orange, 30 (88.2%) with erythema, and 31 (91.2%) with edema. The sensitivities of the medical records as compared to the case–control study were 0.8, 0.5, and 0.2 for peau d’orange, erythema, and edema, respectively. Corresponding specificities were 1.0, 0.5, and 1.0. p values for McNemar’s test were <0.05 for all signs. Medical records had data on the extent and duration of signs for at most 27% of cases for which this information was recorded in the case–control study. Twenty-three of the 34 cases (67.6%) had confirmed diagnosis of IBC in their medical records. CONCLUSION: Medical records lacked information on signs/symptoms of IBC, especially erythema and edema, when compared to the case–control study. Deficient medical records could have implications for diagnosis and treatment of IBC and proper documentation of cases in cancer registries.
format Online
Article
Text
id pubmed-5356360
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-53563602017-03-22 Reliability of medical records in diagnosing inflammatory breast cancer in Egypt Le, Lynne Schairer, Catherine Hablas, Ahmed Meza, Jane Watanabe-Galloway, Shinobu Ramadan, Mohamed Merajver, Sofia D. Seifeldin, Ibrahim A. Soliman, Amr S. BMC Res Notes Research Article BACKGROUND: Inflammatory breast cancer (IBC) is a rare, aggressive breast cancer diagnosed clinically by the presence of diffuse erythema, peau d’orange, and edema that arise quickly in the affected breast. This study evaluated the validity of medical records in Gharbiah, Egypt in identifying clinical signs/symptoms of IBC. For 34 IBC cases enrolled in a case–control study at the Gharbiah Cancer Society and Tanta Cancer Center, Egypt (2009–2010), we compared signs/symptoms of IBC noted in medical records to those recorded on a standardized form at the time of IBC diagnosis by clinicians participating in the case–control study. We calculated the sensitivity and specificity of medical records as compared to the case–control study for recording these signs/symptoms. We also performed McNemar’s tests. RESULTS: In the case–control study, 32 (94.1%) IBC cases presented with peau d’orange, 30 (88.2%) with erythema, and 31 (91.2%) with edema. The sensitivities of the medical records as compared to the case–control study were 0.8, 0.5, and 0.2 for peau d’orange, erythema, and edema, respectively. Corresponding specificities were 1.0, 0.5, and 1.0. p values for McNemar’s test were <0.05 for all signs. Medical records had data on the extent and duration of signs for at most 27% of cases for which this information was recorded in the case–control study. Twenty-three of the 34 cases (67.6%) had confirmed diagnosis of IBC in their medical records. CONCLUSION: Medical records lacked information on signs/symptoms of IBC, especially erythema and edema, when compared to the case–control study. Deficient medical records could have implications for diagnosis and treatment of IBC and proper documentation of cases in cancer registries. BioMed Central 2017-03-16 /pmc/articles/PMC5356360/ /pubmed/28302157 http://dx.doi.org/10.1186/s13104-017-2433-z Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Le, Lynne
Schairer, Catherine
Hablas, Ahmed
Meza, Jane
Watanabe-Galloway, Shinobu
Ramadan, Mohamed
Merajver, Sofia D.
Seifeldin, Ibrahim A.
Soliman, Amr S.
Reliability of medical records in diagnosing inflammatory breast cancer in Egypt
title Reliability of medical records in diagnosing inflammatory breast cancer in Egypt
title_full Reliability of medical records in diagnosing inflammatory breast cancer in Egypt
title_fullStr Reliability of medical records in diagnosing inflammatory breast cancer in Egypt
title_full_unstemmed Reliability of medical records in diagnosing inflammatory breast cancer in Egypt
title_short Reliability of medical records in diagnosing inflammatory breast cancer in Egypt
title_sort reliability of medical records in diagnosing inflammatory breast cancer in egypt
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356360/
https://www.ncbi.nlm.nih.gov/pubmed/28302157
http://dx.doi.org/10.1186/s13104-017-2433-z
work_keys_str_mv AT lelynne reliabilityofmedicalrecordsindiagnosinginflammatorybreastcancerinegypt
AT schairercatherine reliabilityofmedicalrecordsindiagnosinginflammatorybreastcancerinegypt
AT hablasahmed reliabilityofmedicalrecordsindiagnosinginflammatorybreastcancerinegypt
AT mezajane reliabilityofmedicalrecordsindiagnosinginflammatorybreastcancerinegypt
AT watanabegallowayshinobu reliabilityofmedicalrecordsindiagnosinginflammatorybreastcancerinegypt
AT ramadanmohamed reliabilityofmedicalrecordsindiagnosinginflammatorybreastcancerinegypt
AT merajversofiad reliabilityofmedicalrecordsindiagnosinginflammatorybreastcancerinegypt
AT seifeldinibrahima reliabilityofmedicalrecordsindiagnosinginflammatorybreastcancerinegypt
AT solimanamrs reliabilityofmedicalrecordsindiagnosinginflammatorybreastcancerinegypt